세계 두개내압 모니터링 시장 규모는 2024년 19억 달러에 달했습니다. 향후 IMARC Group은 2033년까지 시장 규모가 31억 달러에 달할 것으로 예상하며, 2025-2033년 연평균 성장률(CAGR)은 5.47%에 달할 것으로 전망하고 있습니다. 외상성 뇌손상 증가, 신경질환 증가, 뇌졸중 유병률 증가, 모니터링 기술 발전, 조기 진단에 대한 인식 증가, 환자 예후 개선의 필요성 등이 시장 성장을 견인하는 주요 요인입니다.
신경질환 유병률 증가
외상성 뇌손상, 뇌졸중, 뇌수두증, 기타 신경계 질환 등의 발병률 증가로 인해 효과적인 모니터링 솔루션이 필요해지면서 ICP(두개내압) 모니터링 장비에 대한 수요가 증가하고 있습니다. 미국 국립보건원(NIH)에 따르면, 인도에서는 매년 150만-200만 명에 가까운 사람들이 부상을 입고, 100만 명이 사망하는 것으로 추정됩니다. 외상성 뇌손상의 주요 원인(60%)은 교통사고이며, 낙상(20-25%), 폭력(10%)이 그 뒤를 잇습니다. 외상성 뇌손상의 15-20%는 손상 시 알코올이 관여하는 것으로 알려져 있습니다. 미국 질병예방통제센터(CDC)에 따르면, 매년 약 250만 명이 외상성 뇌손상(TBI)을 입는 것으로 추정됩니다. 뇌손상은 15-24세 남성에게 가장 많이 발생합니다. 세 미만의 어린이와 75세 이상의 노인도 뇌손상 발생률이 높습니다. 따라서 예측 기간 동안 두개내압 모니터링 시장의 수익은 더욱 증가할 것으로 예상됩니다.
의료 기술의 눈부신 발전
최소침습적 및 비침습적 ICP 모니터링 기술 개발을 포함한 모니터링 기술의 혁신이 증가함에 따라 이러한 장치의 정확성, 안전성, 사용 편의성이 향상되어 시장 성장을 촉진하고 있습니다. 예를 들어, 2024년 6월 네이처지에 게재된 연구 논문에 따르면, 중국 연구팀은 두개 내 신호의 무선 모니터링을 위한 미니 주사형 초음파 센서를 개발하여 현재 임상 장비의 한계를 뛰어넘을 수 있는 대안을 제시했습니다. 이 조사에 따르면, 이 센서는 생분해성 및 자극 반응성 하이드로겔과 특정 음향 반사 스펙트럼을 가진 주기적으로 정렬된 공기 기둥으로 만들어진 8 입방 밀리미터 크기의 입방체입니다. 천자침으로 두개골 내강에 삽입하면 생리적 환경의 변화에 따라 변형되어 반사 초음파의 피크 주파수가 이동하여 외부 초음파 프로브에서 무선으로 측정할 수 있습니다. 이러한 중요한 발전으로 인해 전 세계적으로 두개내압 모니터링 시장의 전망은 매우 밝습니다.
인식 제고와 조기 진단
의료진과 환자들 사이에서 뇌 관련 질환의 조기 진단과 개입의 중요성에 대한 인식이 높아지면서 ICP 모니터링 시스템에 대한 수요가 증가하고 있습니다. 예를 들어, 2024년 3월 킹스칼리지 런던(KCL) 연구진은 신경질환의 조기 진단을 위한 비침습적 뇌 나이 예측 도구를 위한 딥러닝 프레임워크를 개발했습니다. 이 조사에서는 다양한 종류의 자기공명영상(MRI)으로 여러 뇌 모델을 훈련시킨 후, 임상용 모델군을 구축하여 사용할 수 있도록 했습니다. 알츠하이머병, 뇌졸중, 다발성 경화증, 파킨슨병 등의 신경질환은 뇌뿐만 아니라 인체 전체에 있는 신경과 척수에도 영향을 미치는 질환입니다. 이러한 발전은 질병의 조기 진단에 매우 중요하며, 질병의 조기 진단의 중요성에 대한 인식이 높아짐에 따라 두개내압 모니터링 시장 예측에 긍정적인 영향을 미칠 것으로 예상됩니다.
The global intracranial pressure monitoring market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The increasing incidences of traumatic brain injuries, growing neurological disorders, rising prevalence of strokes, advancements in monitoring technology, growing awareness of early diagnosis, and the need for improved patient outcomes are some of the major factors propelling the market growth.
Increasing Prevalence of Neurological Disorders
The rising incidence of conditions such as traumatic brain injuries, strokes, hydrocephalus, and other neurological disorders necessitates effective monitoring solutions, boosting the demand for ICP monitoring devices. According to The National Institute of Health (NIH), it is estimated that nearly 1.5 to 2 million persons are injured and 1 million succumb to death every year in India. Road traffic injuries are the leading cause (60%) of traumatic brain injuries followed by falls (20%-25%) and violence (10%). Alcohol involvement is known to be present among 15%-20% of traumatic brain injuries at the time of injury. According to the Centers for Disease Control and Prevention (CDC), an estimated 2.5 million people sustain a traumatic brain injury (TBI) each year. Brain injuries are most common in men between the ages of 15 to 24. Children under the age of 5 and older adults over age 75 also have a high incidence of brain injury. This is further projected to increase the intracranial pressure monitoring market revenue during the forecast period.
Significant Advancements in Medical Technology
The rising innovations in monitoring technology, including the development of minimally invasive and non-invasive ICP monitoring techniques, have improved the accuracy, safety, and ease of use of these devices, driving market growth. For instance, in June 2024, as published in a research article in Nature journal, a Chinese research team created a mini-injectable ultrasonic sensor for wireless monitoring of intracranial signals, thereby providing an option that goes beyond the limitations of current clinical instruments. According to the study, the sensors are cubes that are eight cubic millimeters in size, and they are made from biodegradable and stimulus-responsive hydrogels and periodically aligned air columns with a specific acoustic reflection spectrum. Implanted into intracranial space with a puncture needle, the devices can deform in response to physiological environmental changes, resulting in peak frequency shifts of reflected ultrasound waves that can be wirelessly measured by an external ultrasound probe. Such significant advancements are creating a positive intracranial pressure monitoring market outlook across the globe.
Growing Awareness and Early Diagnosis
Increased awareness about the importance of early diagnosis and intervention for brain-related conditions among healthcare providers and patients fuels the demand for ICP monitoring systems. For instance, in March 2024, researchers from King's College London (KCL) developed a deep learning framework for a non-invasive brain-age prediction tool for the early diagnosis of neurological diseases. The study built and made available a set of models for clinical use after training multiple brain models from a variety of magnetic resonance image (MRI) types. Neurological disorders, such as Alzheimer's disease, strokes, multiple sclerosis, and Parkinson's disease, are conditions that affect the brain as well as the nerves found throughout the human body and spinal cord. Advancements like these are pivotal to the early diagnosis of the diseases, which, when coupled with the rising awareness regarding the significance of the early disease diagnosis, are expected to have a positive impact on the intracranial pressure monitoring market forecast.
Monitors accounts for the majority of the market share
The demand for monitors in the market is driven by the increasing prevalence of traumatic brain injuries, strokes, and neurological disorders, necessitating accurate and continuous monitoring. Advancements in medical technology, including non-invasive and minimally invasive monitors, enhance patient safety and comfort, boosting their adoption. The growing awareness about early diagnosis and intervention for brain-related conditions, coupled with improved healthcare infrastructure and increased healthcare spending, particularly in developed regions, further propels the intracranial pressure monitoring demand.
Invasive holds the largest share of the industry
The demand for invasive technology in the market is driven by its high accuracy and reliability in critical care settings. Pioneering the many intracranial pressure monitoring market recent developments, invasive technology is essential for managing severe traumatic brain injuries, hydrocephalus, and other neurological conditions requiring precise pressure measurements. Additionally, advancements in invasive monitoring devices have enhanced safety and ease of use, further boosting their adoption. The ability to provide continuous, real-time data critical for timely clinical interventions also drives the demand for invasive ICP monitoring technologies, thereby creating a positive market outlook across the globe.
Intraventricular represents the leading market segment
The demand for intraventricular monitoring in the market is driven by its superior accuracy and ability to both monitor and drain cerebrospinal fluid (CSF), making it crucial for managing severe traumatic brain injuries and hydrocephalus. This method provides continuous, real-time pressure data and therapeutic intervention capabilities, essential for critical care. Additionally, the increasing prevalence of neurological disorders and the need for precise intracranial pressure management in intensive care units further boost the demand for intraventricular monitoring.
Traumatic Brain Injury exhibits a clear dominance in the market
The demand for intracranial pressure (ICP) monitoring in traumatic brain injury (TBI) is driven by the need for precise, real-time pressure data to prevent secondary brain damage. Early and accurate ICP monitoring is crucial for guiding treatment decisions, reducing mortality rates, and improving patient outcomes. The high prevalence of TBIs, particularly from accidents and sports injuries, coupled with advancements in monitoring technology and increased awareness among healthcare providers, are further propelling the demand for ICP monitoring in this application.
Hospitals dominates the market
The demand for intracranial pressure (ICP) monitoring in hospitals is driven by the high incidence of traumatic brain injuries, strokes, and neurological disorders requiring critical care. Hospitals are equipped with advanced medical infrastructure and specialized staff capable of utilizing ICP monitoring technologies effectively. The emphasis on early diagnosis and intervention, coupled with the need for continuous, accurate monitoring in intensive care units, further boosts demand. Additionally, hospitals' ability to integrate the latest advancements in ICP monitoring ensures better patient outcomes and drives the intracranial pressure monitoring market growth.
North America leads the market, accounting for the largest intracranial pressure monitoring market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for intracranial pressure monitoring.
In North America, the intracranial pressure monitoring market is driven by the high prevalence of traumatic brain injuries and neurological disorders, advanced healthcare infrastructure, and significant healthcare expenditure. According to a study by the University of Pennsylvania, each year, an estimated 2 million Americans suffer some form of traumatic brain injury. Brain injury is suffered by someone in America, usually a young person, every 15 seconds. Each year, approximately 100,000 people die from TBI and 500,000 more are permanently disabled. 80,000 people experience the onset of long-term disability following a severe brain injury annually. Approximately 5.3 million Americans, more than 2% of the US population - are living with a disability that results from TBI. The cost of treating, rehabilitating, and caring for the victims of traumatic brain injury costs the U.S. approximately $30 billion each year. The region's strong adoption of innovative medical technologies and increased awareness of early diagnosis and intervention for brain-related conditions further boost demand. Additionally, the presence of leading medical device manufacturers and ongoing research and development activities contribute to the market's growth in North America.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)